Clinicial Trials Directory–
Show: » All Trials | Adult | Pediatric

Oncology Trials

Drug Intervention Trials that are Recruiting

Study Title
Investigators
Disease Categories
AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer
Dr. Sandy Srinivas
Prostatic Neoplasms
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Peter L Greenberg
Jason Robert Gotlib
Bruno Carneiro de Medeiros
Harlan Pinto
Leukemia
Bone Marrow Neoplasms
Phase II Trial - Breast Cancer Chemoprevention by Lovastatin
Allison Walsh Kurian
Ava Kwong
James M Ford
Breast Cancer
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancer
Dr. Sandy Srinivas
Natalia Colocci
Prostatic Neoplasms
Phase 1 Trial of Oral Ixabepilone
Branimir I Sikic
Ranjana Hira Advani
Dr. A. Dimitrios Colevas
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Pamela Kunz
Heather A. Wakelee
Carcinomas (including Squamous Cell and Adenocarcinoma)
Temsirolimus and Sorafenib as Second-Line Therapy in Patients With Advanced RCC Who Failed First-Line Sunitinib
Dr. Sandy Srinivas
Kidney Neoplasms
Carcinoma, Renal Cell
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
George Albert Fisher M.D. Ph.D.
James M Ford
Pamela Kunz
Stomach Cancer
A Pivotal Open-Label Trial of SGN-35 for Hodgkin Lymphoma
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Daniel Aaron Pollyea
Lymphoma, Hodgkin Disease
Hodgkin Disease
Clinical Trial of PXD101 in Patients With T-Cell Lymphomas
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Youn H Kim
Mark Lee
Lymphoma, T-Cell
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Dr. Sandy Srinivas
Russell Pachynski
Stefanie S. Jeffrey M.D.
Prostatic Neoplasms
AZD0530 in Treating Patients With Relapsed or Refractory Thymoma or Thymic Cancer
Heather A. Wakelee
Yelena Krupitskaya
Thymoma
Thymus Neoplasms
Ph I/II of Vitamin D on Bone Mineral Density & Markers of Bone Resorption
Eva Balint
Robert W Carlson
Breast Cancer
Bone Diseases
A Phase I Dose Escalation Study of Weekly SGN-35 Alone and in Combination With Gemcitabine in HL
Sandra Jeane Horning
Lymphoma, Hodgkin Disease
Hodgkin Disease
Blood Cancer
Phase I Vandetanib plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal Cancer
George Albert Fisher M.D. Ph.D.
Branimir I Sikic
Dr Mehrdad Mobasher M.D., M.P.H.
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Randomized Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
Dr. Sandy Srinivas
Lauren Harshman
Bladder Cancer
A Phase 1 Study of an Oral VEGFR Inhibitor (AV-951) in Combination With Torisel in Renal Cell Cancer
Dr. Sandy Srinivas
Lauren Harshman
Carcinoma, Renal Cell
Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
Dr. Sandy Srinivas
Lauren Harshman
Urogenital Cancer
Phase II Anastrozole and ZD6474 in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer
Dr. Ellie Guardino MD/PhD
Robert W Carlson
Bruce Lewis Daniel
Frederick M. Dirbas
Irene L. Wapnir
Melinda Telli
Breast Cancer
Study of XL518 in Adults With Solid Tumors
Branimir I Sikic
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Heather A. Wakelee
Dr. Peter S. Galatin
Carcinomas (including Squamous Cell and Adenocarcinoma)
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer
Harlan Pinto
Lung Cancer
A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Second-Line Treatment of Patients With DLBCL
Andy Chen
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Lymphoma, Diffuse
Lymphoma, B-Cell
Lymphoma, Non-Hodgkin
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
Dr. Sandy Srinivas
Kidney Diseases
Carcinoma, Renal Cell
A Phase 1 Dose Escalation Study of OMP-21M18 in Subjects With Solid Tumors
Branimir I Sikic
Ranjana Hira Advani
Dr. A. Dimitrios Colevas
Charlotte D Jacobs
Pamela Kunz
Amy Deanne McMullen
Heather A. Wakelee
Carcinomas (including Squamous Cell and Adenocarcinoma)
Phase I Dose-Escalation Study of Btk Inhibitor PCI-32765 in Recurrent B Cell Lymphoma
Ranjana Hira Advani
Kristen N. Ganjoo
Daniel Aaron Pollyea
Lymphoma, Non-Hodgkin
Leukemia, Lymphocytic, Chronic
Lymphoma, Small-Cell
Phase 3 Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer
Dr. A. Dimitrios Colevas
Harlan Pinto
Neuroendocrine Tumors
Thyroid Cancer
BIBW 2992 in Head&Neck Cancer
Dr. A. Dimitrios Colevas
Harlan Pinto
Head and Neck Cancer
Carcinoma, Squamous Cell
A Phase II Study of GSK1363089 (Formerly XL880) for Metastatic Gastric Cancer
James M Ford
George Albert Fisher M.D. Ph.D.
Stomach Cancer
CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Normal Estradiol
Heather A. Wakelee
Lung Cancer
A Study of XL184 With or Without Erlotinib in Adults With Non-Small Cell Lung Cancer
Heather A. Wakelee
Dr. A. Dimitrios Colevas
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Branimir I Sikic
Carcinoma, Non-Small-Cell Lung
Phase II Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel with Lapatinib in Stage II/III Her2Neu+ Breast Cancer
Dr. Ellie Guardino MD/PhD
Robert W Carlson
Breast Cancer
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
Kristen N. Ganjoo
Sarcoma
Development of Vitamin D as a Therapy for Breast Cancer - Phase II
Robert W Carlson
David Feldman
Kristin Jensen
Breast Cancer
Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy
Ronald Levy
Ranjana Hira Advani
Lymphoma
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery
Harlan Pinto
Denise L Johnson
Susan M. Swetter
Sunil Arani Reddy
Melanoma
Phase III Study of Aflibercept vs Placebo for Metastatic Androgen-Independent Prostate Cancer
Dr. Sandy Srinivas
Prostatic Neoplasms
Neoplasm Metastasis
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Heather A. Wakelee
Harlan Pinto
Lung Cancer
Phase II study of Atorvastatin safety and antitumor effects in non-Hodgkin's Lymphoma
Dean Felsher
Alice Fan
Dr. Christina S. Kong
Yasodha Natkunam
Steven Edward Coutre
Leukemia
Lymphoma, Non-Hodgkin
Ph I Dose-Escalation of AEG40826-2HCI for Advanced Solid Tumors
Branimir I Sikic
Ranjana Hira Advani
Dr. A. Dimitrios Colevas
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Yelena Krupitskaya
Heather A. Wakelee
Brain Cancer
Cancer
A Phase II Intratumoral Injection PF-3512676 plus Local Radiation in Low-Grade B-Cell Lymphomas
Ronald Levy
Joshua Brody
Lymphoma
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers
Sandra Jeane Horning
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Phase II Gemcitabine, Carboplatin & PARP Inhibitor BSI-201 in Neoadjuvant Tx of Triple-Neg Breast CA
Allison Walsh Kurian
James M Ford
Kristin Jensen
Melinda Telli
Breast Cancer
An Observational Study of the Ethnic Impact of Patients Undergoing 2nd Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed
Heather A. Wakelee
Dr. A. Dimitrios Colevas
Charlotte D Jacobs
George Albert Fisher M.D. Ph.D.
Lung Cancer
Ph II, Multicenter, Simon 2-Stage of R788 For Relapsed or Refractory T-Cell Lymphoma
Ranjana Hira Advani
Andy Chen MD PhD
Kristen N. Ganjoo
Sandra Jeane Horning
Ronald Levy
Lymphoma, T-Cell
Ph III Randomized Study of Four Weeks of High-Dose IFN-á2b for Microscopic Melanoma
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Harlan Pinto
Sunil Arani Reddy
Melanoma
Skin Cancers
SARC 009: A Phase II Trial of Dasatinib in Advanced Sarcomas
Kristen N. Ganjoo
Charlotte D Jacobs
Hemangiopericytoma
Nerve Sheath Neoplasms
Rhabdomyosarcoma
Chordoma
Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine Tumors
George Albert Fisher M.D. Ph.D.
James M Ford
Pamela Kunz
Neuroendocrine Tumors
Phase II Gemzar, Taxol & Avastin Combination as 1st Line Tx for Metastatic Breast CA
Dr. Ellie Guardino MD/PhD
Robert W Carlson
Breast Cancer
Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
Dr. Sandy Srinivas
Harlan Pinto
Kidney Neoplasms
Carcinoma, Renal Cell
Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, and Radiation Therapy in Treating Patients With Advanced Nasopharyngeal Carcinoma
Dr. A. Dimitrios Colevas
Quynh-Thu Le
Dr Andrew Quon
Head and Neck Cancer
Safety and Efficacy of RAD001 in Patients With Velcade® Refractory Mantle Cell Lymphoma
Ranjana Hira Advani
Andy Chen MD PhD
Lymphoma, Mantle-Cell
Phase III CHOP + Rituximab vs CHOP + Iodine-131 Monoclonal Anti-B1 Antibody for New Dx Foll NHL
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Michael L Goris
Harlan Pinto
Lymphoma
Study of Pralatrexate and Gemcitabine With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Lymphoproliferative Malignancies
Ranjana Hira Advani
Kristen N. Ganjoo
Lymphoma, Hodgkin Disease
Hodgkin Disease
Lymphoma, Non-Hodgkin
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Richard T. Hoppe
Lymphoma
Lymphoma, Hodgkin Disease
Hodgkin Disease
Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
Sandra Jeane Horning
Harlan Pinto
Brain Cancer
Lymphoma
Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast
Dr. Ellie Guardino MD/PhD
Breast Cancer
A Study of ASA404 or Placebo in Combination With Docetaxel in Second-Line Treatment for (Stage IIIb/IV) Non-Small Cell Lung Cancer (ATTRACT-2)
Heather A. Wakelee
Dr. A. Dimitrios Colevas
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Branimir I Sikic
Lisa Ya Zhou PhD
Lung Cancer
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
George Albert Fisher M.D. Ph.D.
Carcinoid Tumor
A Phase 1/2 Study of Aflibercept Administered in Combination with Pemetrexed and Cisplatin in Patients with Advanced Carcinoma
Heather A. Wakelee
Dr. A. Dimitrios Colevas
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Carcinoma, Non-Small-Cell Lung
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Harlan Pinto
Dr. A. Dimitrios Colevas
Charlotte D Jacobs
Head and Neck Cancer
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Robert W Carlson
Dr. Ellie Guardino MD/PhD
Allison Walsh Kurian
See-Chun Phan
Harlan Pinto
Klaus Porzig
Frank E. Stockdale
Breast Cancer
Study of XL880 in Subjects With Papillary Renal Cell Carcinoma
Dr. Sandy Srinivas
Carcinoma, Papillary
Kidney Neoplasms
Carcinoma, Renal Cell
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients
George Albert Fisher M.D. Ph.D.
Pamela Kunz
Gastrointestinal Stromal Tumors
Treatment of Refractory Metastatic Renal Cell Carcinoma with Bevacizumab and RADOO1
Dr. Sandy Srinivas
Lauren Harshman
Kidney Neoplasms

Other Trials that are Recruiting

Study Title
Investigators
Disease Categories
Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
Dr. Sandy Srinivas
Harlan Pinto
Kidney Neoplasms
Carcinoma, Renal Cell
A Pilot Study Evaluating the Immunologic Status of Patients with HER2+ Breast Cancer
Dr. Ellie Guardino MD/PhD
Breast Cancer
Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy
Ronald Levy
Ranjana Hira Advani
Lymphoma
Phase I/II of a CpG-Activated Whole Cell Vaccine Followed by Autologous “Immunotransplant” for MCL
Ronald Levy
Ranjana Hira Advani
Joshua Brody
Sandra Jeane Horning
Robert S Negrin
Wen-Kai Weng
David Miklos
Lymphoma, Mantle-Cell
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Robert W Carlson
Dr. Ellie Guardino MD/PhD
Allison Walsh Kurian
See-Chun Phan
Harlan Pinto
Klaus Porzig
Frank E. Stockdale
Breast Cancer
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Ronald Levy
Ramsey Cheung
Gideon Gross
Lymphoma, Non-Hodgkin
Phase III CHOP + Rituximab vs CHOP + Iodine-131 Monoclonal Anti-B1 Antibody for New Dx Foll NHL
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Michael L Goris
Harlan Pinto
Lymphoma
Azacitidine With or Without MS-275 in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Peter L Greenberg
Jason Robert Gotlib
Bruno Carneiro de Medeiros
Harlan Pinto
Leukemia
Bone Marrow Neoplasms
Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients
Heather A. Wakelee
Dr Jessica S. Donington
Lung Cancer
Clinical and Pathologic Studies of Patients Undergoing Treatment with EGFR Inhibitors
George Albert Fisher M.D. Ph.D.
Russell Pachynski
Heather A. Wakelee
Head and Neck Cancer
Colorectal Neoplasms
Anal, Colon, and Rectal Cancers
Colonic Neoplasms
Lung Cancer
Colon Cancer
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
James M Ford
Hanlee P. Ji
Vandana Bhardwaj Sharma
Digestive System Neoplasms
Ph III Randomized Study of Four Weeks of High-Dose IFN-á2b for Microscopic Melanoma
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Harlan Pinto
Sunil Arani Reddy
Melanoma
Skin Cancers
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer
Harlan Pinto
Lung Cancer
Biopsy of human tumors for cancer stem cell characterization: a feasibility study
Dr. A. Dimitrios Colevas
Laurie Elizabeth Ailles
Willard E Fee Jr
Dr. Maximilian Diehn MD/PhD
Benzion Joshua
Quynh-Thu Le
Harlan Pinto
Jon Pollack
Dr Michael Kaplan
Michael F Clarke
Head and Neck Cancer
Healing Touch during Chemotherapy Infusions for Women with Breast Cancer
Kathy Turner RN, NP
Dr. Ellie Guardino MD/PhD
Breast Cancer
Combination Chemotherapy Plus Low-Dose Radiation Therapy in Treating Patients With Stage I or Stage IIA Hodgkin's Lymphoma
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Richard T. Hoppe
Lymphoma
Lymphoma, Hodgkin Disease
Hodgkin Disease
Docetaxel, Cisplatin, Fluorouracil, Bevacizumab, and Radiation Therapy in Treating Patients With Advanced Nasopharyngeal Carcinoma
Dr. A. Dimitrios Colevas
Quynh-Thu Le
Dr Andrew Quon
Head and Neck Cancer

Trials not Recruiting

Study Title
Investigators
Disease Categories
Rituximab, Combination Chemotherapy, and Bortezomib in Treating Patients With Untreated Mantle Cell Lymphoma (No longer recruiting)
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Harlan Pinto
Lymphoma
Lymphoma, Mantle-Cell
Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects (Terminated)
Sandra Jeane Horning
Lymphoma, B-Cell
Reticuloendotheliosis
Histiocytosis
Lymphoma, Large-Cell, Diffuse
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-Resistant Prostate Cancer (IPI-504-04) (No longer recruiting)
Dr. Sandy Srinivas
Prostatic Neoplasms
Estradiol Suppression for the treatment of metastatic breast cancer in premenopausal women (No longer recruiting)
Robert W Carlson
Breast Cancer
A Phase II Study of AZD4877 (a Novel Anti-Mitotic Agent) in Advanced Bladder Cancer (No longer recruiting)
Dr. Sandy Srinivas
Lauren Harshman
Ureteral Neoplasms
Pelvic Neoplasms
Kidney Neoplasms
Urethral Neoplasms
Bladder Cancer
Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck (Not yet recruiting)
Dr. A. Dimitrios Colevas
Quynh-Thu Le
Stomatitis
PR-104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer (No longer recruiting)
Dr. A. Dimitrios Colevas
Heather A. Wakelee
Lung Cancer
Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC (No longer recruiting)
Heather A. Wakelee
Walter B Cannon
Dr Jessica S. Donington
Charlotte D Jacobs
Quynh-Thu Le
Dr. Billy W. Loo Jr. M.D. Ph.D.
Branimir I Sikic
Richard I Whyte
Lung Cancer
Phase II trial of bevacizumab in combination with pemetrexed as 2nd line therapy in patients with stable brain metastases from non-small cell lung cancer (No longer recruiting)
Charlotte D Jacobs
Heather A. Wakelee
Neoplasm Metastasis
Lung Cancer
Phase I/II Study of Intratumoral Injection of CPG 7909, a TLR9 Agonist, Combined with Local Radiation for Patients with Recurrent Mycosis Fungoides. (Terminated)
Ronald Levy
Richard T. Hoppe
Youn H Kim
Eunice Tsai
Mycosis Fungoides
Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic Cancer (Completed)
George Albert Fisher M.D. Ph.D.
Joan K. Frisoli MD, PhD
Albert Koong
Yasodha Natkunam
Edgar G Engleman
Wenru Song
Jacques Van Dam M.D., Ph.D.
Pancreatic Cancer
Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms (No longer recruiting)
Kristen N. Ganjoo
Ranjana Hira Advani
Sandra Jeane Horning
Harlan Pinto
Lymphoma
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer (Suspended)
George Albert Fisher M.D. Ph.D.
Harlan Pinto
Colonic Neoplasms
Colon Cancer
Study of SGN-40 (Anti-huCD40 mAb) in Patients With Relapsed Diffuse Large B-Cell Lymphoma (No longer recruiting)
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Lymphoma, B-Cell
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma (Completed)
Sandra Jeane Horning
Lymphoma, Non-Hodgkin
Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated w/RCHOP +/- XRT (No longer recruiting)
Kristen N. Ganjoo
Lymphoma
Lymphoma, Non-Hodgkin
Study of XL647 Administered Orally Daily to Patients With Solid Tumors (No longer recruiting)
Branimir I Sikic
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Heather A. Wakelee
Cancer
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck (Completed)
Dr. A. Dimitrios Colevas
Harlan Pinto
Head and Neck Cancer
Carcinoma, Squamous Cell
Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer (No longer recruiting)
James M Ford
Hanlee P. Ji
Vandana Bhardwaj Sharma
Breast Cancer
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma (No longer recruiting)
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Mark Lee
Lymphoma, T-Cell, Peripheral
A Dose and Schedule Finding Trial With AMG 531 for CIT in Adults With Lymphoma (Completed)
Ranjana Hira Advani
Kristen N. Ganjoo
Sandra Jeane Horning
Lymphoma
Thrombocytopenia
Lymphoma, Non-Hodgkin
Study of XL647 in Subjects With NSCLC Who Have Progressed After Responding to Treatment With Gefitinib or Erlotinib (No longer recruiting)
Heather A. Wakelee
Dr. A. Dimitrios Colevas
George Albert Fisher M.D. Ph.D.
Charlotte D Jacobs
Carcinoma, Non-Small-Cell Lung
MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer (Completed)
Dr. Sandy Srinivas
Prostatic Neoplasms
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma (Completed)
Harlan Pinto
Denise L Johnson
Susan M. Swetter
Melanoma
Skin Cancers
Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer (Completed)
Heather A. Wakelee
Charlotte D Jacobs
Carcinoma, Small Cell
Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma (No longer recruiting)
Harlan Pinto
Sunil Arani Reddy
Melanoma
Skin Cancers
Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors (Completed)
Ranjana Hira Advani
Andy Chen
Charlotte D Jacobs
Heather A. Wakelee
Carcinomas (including Squamous Cell and Adenocarcinoma)
Docetaxel With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer (No longer recruiting)
Harlan Pinto
Dr. A. Dimitrios Colevas
Head and Neck Cancer
A Phase I/II Study of HKI-272 in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer (No longer recruiting)
Branimir I Sikic
George Albert Fisher M.D. Ph.D.
Dr. Ellie Guardino MD/PhD
Heather A. Wakelee
Breast Cancer
Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium (No longer recruiting)
Dr. Sandy Srinivas
Harlan Pinto
Ureteral Neoplasms
Kidney Neoplasms
Urethral Neoplasms
Bladder Cancer
Intellectual Impairment in Women With Breast Cancer (Not yet recruiting)
Shelli Kesler
Joachim Franz Hallmayer
David Spiegel
Robert W Carlson
Breast Cancer
Rituximab, Combination Chemotherapy, and Bortezomib in Treating Patients With Untreated Mantle Cell Lymphoma (No longer recruiting)
Sandra Jeane Horning
Harlan Pinto
Lymphoma
Rituximab and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Non-Hodgkin's Lymphoma (No longer recruiting)
Ranjana Hira Advani
Sandra Jeane Horning
Kristen N. Ganjoo
Michael L Goris
Harlan Pinto
Lymphoma
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer (excluding squamous cell) (No longer recruiting)
Heather A. Wakelee
Kristen N. Ganjoo
Charlotte D Jacobs
Branimir I Sikic
Kent Mark-Josef Adler
Lung Cancer
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma (No longer recruiting)
Sandra Jeane Horning
Ranjana Hira Advani
Harlan Pinto
Kristen N. Ganjoo
Lymphoma
A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer (No longer recruiting)
Heather A. Wakelee
Carcinoma, Non-Small-Cell Lung
Lung Diseases
Carcinomas (including Squamous Cell and Adenocarcinoma)
Thoracic Neoplasms
Neoplasms, Glandular and Epithelial
Lung Cancer
Anastrozole and Gefitinib Compared With Fulvestrant and Gefitinib in Treating Postmenopausal Women With Recurrent or Metastatic Breast Cancer (No longer recruiting)
Robert W Carlson
See-Chun Phan
Klaus Porzig
Cathie Tuck Chung
Frank E. Stockdale
Richard Shapiro
Breast Cancer
A Phase 1b/2 Study of AMG 655 in Combination With Doxorubicin for the First-Line Treatment of Unresectable Soft Tissue Sarcoma (No longer recruiting)
Kristen N. Ganjoo
Charlotte D Jacobs
Sarcoma
Neoplasm Metastasis
Phase I/II CPG 7909 + Local XRT in Recurrent Low-Grade Lymphomas (No longer recruiting)
Ronald Levy
Weiyun Ai
Joshua Brody
Richard T. Hoppe
Sandra Jeane Horning
Youn H Kim
Susan J Knox
Sabine Kohler
Irene L. Wapnir
Lymphoma, Non-Hodgkin
Phase I/II PTK787/ZK 222584 and Gemcitabine in Advanced Pancreatic Cancer (No longer recruiting)
George Albert Fisher M.D. Ph.D.
Dr Terry Desser
James M Ford
Albert Koong
Jeffrey A. Norton
Dr Andrew Quon
Branimir I Sikic
Pancreatic Cancer
R1507 in Patients With Recurrent or Refractory Sarcomas (No longer recruiting)
Kristen N. Ganjoo
Charlotte D Jacobs
Dr. Neyssa Marina
Sarcoma
Treatment Protocol for the Use of Sorafenib in Patients With Advanced Renal Cell Carcinoma (No longer recruiting)
Dr. Sandy Srinivas
Kidney Neoplasms
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer (Completed)
Dr. Sandy Srinivas
Prostatic Neoplasms
A Study Evaluating the Efficacy and Safety of Sutinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R) (No longer recruiting)
Dr. Sandy Srinivas
Kidney Neoplasms
Carcinoma, Renal Cell
A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma (Completed)
Dr. Sandy Srinivas
Kidney Neoplasms
Sorafenib in Treating Patients With Refractory Non-Small Cell Lung Cancer (No longer recruiting)
Harlan Pinto
Charlotte D Jacobs
Heather A. Wakelee
Lung Cancer
A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) (No longer recruiting)
Robert W Carlson
Breast Cancer
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer (No longer recruiting)
Dr. Ellie Guardino MD/PhD
Robert W Carlson
Breast Cancer
Phase 2 Trial of Enzastaurin in Prostate Cancer in Patients Who Have Had Hormonal and Chemotherapy (No longer recruiting)
Dr. Sandy Srinivas
Prostatic Neoplasms
Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma (No longer recruiting)
Kristen N. Ganjoo
Ronald Levy
Wen-Kai Weng
Lymphoma, Non-Hodgkin
Rituximab in Treating Patients With Hodgkin's Lymphoma (No longer recruiting)
Sandra Jeane Horning
Ranjana Hira Advani
Richard T. Hoppe
Lymphoma
Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Lymphoma (No longer recruiting)
Sandra Jeane Horning
Ranjana Hira Advani
Kristen N. Ganjoo
Harlan Pinto
Michael L Goris
Lymphoma
Safety Study of Cetuximab in combination with Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer (Completed)
George Albert Fisher M.D. Ph.D.
Branimir I Sikic
James M Ford
Albert Koong
Timothy Kuo
Robert Rouse
Dr Andrew Shelton
Jacques Van Dam M.D., Ph.D.
Mark Lane Welton
Harvey S Young
Rectal Cancer
A Pilot Study Evaluating Oral Triamcinalone in Patients with Androgen Independent Prostate Cancer (Completed)
Dr. Sandy Srinivas
Prostatic Neoplasms
A Phase II Trial of Calcitriol and Naproxen in Patients with Recurrent Prostate Cancer (Suspended)
Dr. Sandy Srinivas
Natalia Colocci
David Feldman
Prostatic Neoplasms
Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma (No longer recruiting)
Ranjana Hira Advani
Sandra Jeane Horning
Harlan Pinto
Lymphoma
Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma (Terminated)
Ronald Levy
Lymphoma, Non-Hodgkin
Lymphoma, Follicular
Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples (Completed)
James M Ford
Paul Graham Fisher
Joshua D Schiffman
Brain Cancer
Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer (Completed)
Dr. Sandy Srinivas
Urologic Neoplasms
First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy (Completed)
Dr. Sandy Srinivas
Carcinoma, Transitional Cell
Bladder Cancer

Stanford Medicine Resources:

Footer Links: